Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 463

1.

Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-α.

Chio CC, Chang CH, Wang CC, Cheong CU, Chao CM, Cheng BC, Yang CZ, Chang CP.

BMC Neurosci. 2013 Mar 15;14:33. doi: 10.1186/1471-2202-14-33.

2.

Etanercept attenuates traumatic brain injury in rats by reducing brain TNF- α contents and by stimulating newly formed neurogenesis.

Cheong CU, Chang CP, Chao CM, Cheng BC, Yang CZ, Chio CC.

Mediators Inflamm. 2013;2013:620837. doi: 10.1155/2013/620837. Epub 2013 Apr 21.

3.

Therapeutic evaluation of etanercept in a model of traumatic brain injury.

Chio CC, Lin JW, Chang MW, Wang CC, Kuo JR, Yang CZ, Chang CP.

J Neurochem. 2010 Nov;115(4):921-9. doi: 10.1111/j.1471-4159.2010.06969.x. Epub 2010 Sep 28.

4.
5.

Therapeutic efficacy of Neuro AiD™ (MLC 601), a traditional Chinese medicine, in experimental traumatic brain injury.

Tsai MC, Chang CP, Peng SW, Jhuang KS, Fang YH, Lin MT, Tsao TC.

J Neuroimmune Pharmacol. 2015 Mar;10(1):45-54. doi: 10.1007/s11481-014-9570-0. Epub 2014 Oct 21.

PMID:
25331680
6.

Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.

Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, DePuy V.

CNS Drugs. 2012 Dec;26(12):1051-70. doi: 10.1007/s40263-012-0013-2.

PMID:
23100196
7.

Direct application of the TNF-alpha inhibitor, etanercept, does not affect CGRP expression and phenotypic change of DRG neurons following application of nucleus pulposus onto injured sciatic nerves in rats.

Norimoto M, Ohtori S, Yamashita M, Inoue G, Yamauchi K, Koshi T, Suzuki M, Orita S, Eguchi Y, Sugiura A, Ochiai N, Takaso M, Takahashi K.

Spine (Phila Pa 1976). 2008 Oct 15;33(22):2403-8. doi: 10.1097/BRS.0b013e31818441a2.

PMID:
18824950
8.

Effect of etanercept and lithium chloride on preventing secondary tissue damage in rats with experimental diffuse severe brain injury.

Ekici MA, Uysal O, Cikriklar HI, Özbek Z, Turgut Cosan D, Baydemir C, Kazanci B, Hafizoğlu D.

Eur Rev Med Pharmacol Sci. 2014;18(1):10-27.

9.

Microglial activation induced by traumatic brain injury is suppressed by postinjury treatment with hyperbaric oxygen therapy.

Lim SW, Wang CC, Wang YH, Chio CC, Niu KC, Kuo JR.

J Surg Res. 2013 Oct;184(2):1076-84. doi: 10.1016/j.jss.2013.04.070. Epub 2013 May 21.

PMID:
23726237
10.

Tumor necrosis factor-α antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury.

Chen KB, Uchida K, Nakajima H, Yayama T, Hirai T, Watanabe S, Guerrero AR, Kobayashi S, Ma WY, Liu SY, Baba H.

Spine (Phila Pa 1976). 2011 Aug 1;36(17):1350-8. doi: 10.1097/BRS.0b013e3181f014ec.

PMID:
21224756
11.

Microglial activation as a compelling target for treating acute traumatic brain injury.

Chio CC, Lin MT, Chang CP.

Curr Med Chem. 2015;22(6):759-70. Review.

PMID:
25386818
12.

Inflammatory cytokine receptor blockade in a rodent model of mild traumatic brain injury.

Perez-Polo JR, Rea HC, Johnson KM, Parsley MA, Unabia GC, Xu GY, Prough D, DeWitt DS, Paulucci-Holthauzen AA, Werrbach-Perez K, Hulsebosch CE.

J Neurosci Res. 2016 Jan;94(1):27-38. doi: 10.1002/jnr.23617. Epub 2015 Jul 14.

PMID:
26172557
13.

Tumor necrosis factor alpha expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature.

Vitarbo EA, Chatzipanteli K, Kinoshita K, Truettner JS, Alonso OF, Dietrich WD.

Neurosurgery. 2004 Aug;55(2):416-24; discussion 424-5.

PMID:
15271250
14.

The neuroprotective effect of modified "Shengyu" decoction is mediated through an anti-inflammatory mechanism in the rat after traumatic brain injury.

Zhao GW, Wang Y, Li YC, Jiang ZL, Sun L, Xi X, He P, Wang GH, Xu SH, Ma DM, Ke KF.

J Ethnopharmacol. 2014;151(1):694-703. doi: 10.1016/j.jep.2013.11.041. Epub 2013 Dec 1.

PMID:
24296086
15.

Pretreatment with the tumor nerosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury.

Choi DE, Jeong JY, Lim BJ, Na KR, Shin YT, Lee KW.

Transplant Proc. 2009 Nov;41(9):3590-6. doi: 10.1016/j.transproceed.2009.05.042.

PMID:
19917350
16.

Potential role of A2A adenosine receptor in traumatic optic neuropathy.

Ahmad S, Fatteh N, El-Sherbiny NM, Naime M, Ibrahim AS, El-Sherbini AM, El-Shafey SA, Khan S, Fulzele S, Gonzales J, Liou GI.

J Neuroimmunol. 2013 Nov 15;264(1-2):54-64. doi: 10.1016/j.jneuroim.2013.09.015. Epub 2013 Sep 21.

PMID:
24090652
17.

Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.

Tuttolomondo A, Pecoraro R, Pinto A.

Drug Des Devel Ther. 2014 Nov 7;8:2221-38. doi: 10.2147/DDDT.S67655. eCollection 2014. Review.

18.

Tumor necrosis factor-α inhibition attenuates middle cerebral artery remodeling but increases cerebral ischemic damage in hypertensive rats.

Pires PW, Girgla SS, Moreno G, McClain JL, Dorrance AM.

Am J Physiol Heart Circ Physiol. 2014 Sep 1;307(5):H658-69. doi: 10.1152/ajpheart.00018.2014. Epub 2014 Jul 11.

19.

Neuronal damage and functional deficits are ameliorated by inhibition of aquaporin and HIF1α after traumatic brain injury (TBI).

Shenaq M, Kassem H, Peng C, Schafer S, Ding JY, Fredrickson V, Guthikonda M, Kreipke CW, Rafols JA, Ding Y.

J Neurol Sci. 2012 Dec 15;323(1-2):134-40. doi: 10.1016/j.jns.2012.08.036. Epub 2012 Oct 3.

PMID:
23040263
20.

Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury.

He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG.

Exp Neurol. 2004 Oct;189(2):404-12.

PMID:
15380490

Supplemental Content

Support Center